Patient Guide: A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 226 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03682536
Status: ACTIVE_NOT_RECRUITING
Condition: Myelodysplastic Syndromes
Phase: PHASE3

Find a Study Location Near You

This study is available at 226 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Berkeley, California
  • San Diego, California
  • Whittier, California
  • • And 223 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily